㈜아크로셀바이오사이언스

{
  "address": "서울특별시 동대문구",
  "ceo_name": "송병호",
  "certificate": [
    {
      "cert_number": "20220127010113",
      "changes": "",
      "disclosure_date": "2022-01-27",
      "first_cert_date": "2022-01-26",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2022-01-26 ~ 2025-01-25"
    },
    {
      "cert_number": "20250204010002",
      "changes": "",
      "disclosure_date": "2025-02-04",
      "first_cert_date": "2022-01-26",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2025-01-26 ~ 2028-01-25"
    }
  ],
  "company_name": "㈜아크로셀바이오사이언스",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 256365000,
      "cost_of_sales": 0,
      "current_assets": 611623000,
      "current_liabilities": 155558000,
      "gross_profit": 0,
      "net_income": -795165000,
      "net_income_bs": -795165000,
      "non_current_assets": 97409000,
      "non_current_liabilities": 152950000,
      "non_operating_expenses": 4483000,
      "non_operating_income": 182641000,
      "operating_profit": -973323000,
      "revenue": 0,
      "sga_expenses": 973323000,
      "total_assets": 709032000,
      "total_equity": 400524000,
      "total_liabilities": 308508000
    },
    "2023": {
      "capital_stock": 256365000,
      "cost_of_sales": 0,
      "current_assets": 90995000,
      "current_liabilities": 254006000,
      "gross_profit": 0,
      "net_income": -769677000,
      "net_income_bs": -769677000,
      "non_current_assets": 87983000,
      "non_current_liabilities": 294124000,
      "non_operating_expenses": 10761000,
      "non_operating_income": 435570000,
      "operating_profit": -1194486000,
      "revenue": 0,
      "sga_expenses": 1194486000,
      "total_assets": 178978000,
      "total_equity": -369152000,
      "total_liabilities": 548130000
    },
    "2024": {
      "capital_stock": 256365000,
      "cost_of_sales": 0,
      "current_assets": 28267000,
      "current_liabilities": 498244000,
      "gross_profit": 9091000,
      "net_income": -214289000,
      "net_income_bs": -214289000,
      "non_current_assets": 65478000,
      "non_current_liabilities": 178942000,
      "non_operating_expenses": 31728000,
      "non_operating_income": 60206000,
      "operating_profit": -242767000,
      "revenue": 9091000,
      "sga_expenses": 251858000,
      "total_assets": 93745000,
      "total_equity": -583441000,
      "total_liabilities": 677186000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "384,000,000",
      "changes": "384,000,000",
      "date": "2021-08-31"
    },
    {
      "amount": "384,750,000",
      "changes": "384,750,000",
      "date": "2021-08-31"
    }
  ],
  "main_products": "첨단바이오 의약품 연구개발",
  "phone": "02-2135-****",
  "years": [
    2024,
    2023,
    2022
  ]
}